The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
Business Of Biotech - Podcast autorstwa Matt Pillar - Poniedziałki
Kategorie:
We love to hear from our listeners. Send us a message. The Business of Biotech kicks off our Cell & Gene Miniseries with Dr. Carsten Brunn, President & CEO at Selecta Biosciences. Guest host Erin Harris, chief editor at cellandgene.com, joins us for a discussion on Selecta's ImmTOR platform and how the company is addressing the immunogenicity of adeno-associated virus (AAV) vectors challenge faced by gene therapy companies.Access this and hundreds of episodes of the Business of Biotec...
